Advertisement

A Bleeding GIST Managed with Octreotide

Published:February 20, 2021DOI:https://doi.org/10.1016/j.amjmed.2021.01.030
      Gastrointestinal bleeding (30%-40% of cases) is the most common clinical presentation of symptomatic gastrointestinal stromal tumors (GIST).
      • Rammohan A
      • Sathyanesan J
      • Rajendran K
      • et al.
      A gist of gastrointestinal stromal tumors: A review.
      The current literature suggest that hemorrhage indicates a poor prognosis and surgical intervention is considered the optimal treatment option for a hemorrhagic GIST.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rammohan A
        • Sathyanesan J
        • Rajendran K
        • et al.
        A gist of gastrointestinal stromal tumors: A review.
        World J Gastrointest Oncol. 2013; 5: 102-112https://doi.org/10.4251/wjgo.v5.i6.102
        • Chaudhry R
        • Singh B
        • Subhas P.
        Octreotide in Gastroenterology.
        Med J Armed Forces India. 1997; 53: 293-294
        • Reubi JC
        • Schaer JC
        • Laissue JA
        • Waser B.
        Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels.
        Metabolism. 1996; 45: 39-41
        • Nevens F.
        Review article: a critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage.
        Aliment Pharmacol Ther. 2004; 20: 18-23
        • Clarke DL
        • McKune A
        • Thomson SR.
        Octreotide lowers gastric mucosal blood flow in normal and portal hypertensive stomachs.
        Surg Endosc. 2003; 17: 1570-1572
        • Sgouros SN
        • Bergele C
        • Viazis N
        • Avgerinos A.
        Somatostatin and its analogues in peptic ulcer bleeding: facts and pathophysiological aspects.
        Dig Liver Dis. 2006; 38: 143-148
        • Arabi Y
        • Al Knawy B
        • Barkun AN
        • Bardou M
        Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin?.
        Crit Care. 2006; 10: 218https://doi.org/10.1186/cc4958
        • Imperiale TF
        • Birgisson S.
        Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis [published correction appears in Ann Intern Med 1998 Feb 1;128(3):245].
        Ann Intern Med. 1997; 127: 1062-1071